Like Healthcare Business Insights

closed 5/14/2015 via PR Newswire

Decision Resources Group, acquired Healthcare Business Insights

See 117 Comparable Transactions
synopsis: Decision Resources Group (DRG), a subsidiary of Piramal Enterprises Ltd., announced that it has acquired Healthcare Business Insights (HBI), a trusted provider of best practice research, training and services to more than 1,400 hospitals across the U.S. HBI's member-centric Academies enable hospitals to understand how to address critical issues.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions. "
 target: Healthcare Business Insights
Healthcare Business Insights (HBI) is a leading provider of in-depth research and thoughtful insights across the core business functions found in hospitals and health systems nationwide. HBI's membership programs include Revenue Cycle, IT, Supply Chain and Cost & Quality.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/7/2016 via PR Newswire

Rizk Ventures, acquired Workforce Prescriptions (WRx)

See 88 Comparable Transactions
synopsis: Rizk Ventures, a privately-held investment firm that focuses on investment activities, announced it has acquired Workforce Prescriptions, a provider of Software-as-a-Service solutions to the healthcare industry with a focus on assisting hospitals in significantly decreasing costs and improving outcomes without reducing staff.
buyer: Rizk Ventures
Rizk Ventures is a privately-held investment firm based in New York. Rizk Ventures focuses on investment activities in the areas of Venture Capital, Private Equity, Real Estate, and Special Opportunities. "
 target: Workforce Prescriptions (WRx)
Workforce Prescriptions (WRx) is an evidence-based consulting firm that provides assistance to hospitals desiring to: Reduce their cost of labor without reducing staff, Reduce their Length of stay without jeopardizing quality and Improve productivity by designing more efficient work processes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/25/2011 via Market Wire

Analytix On Demand, Inc., acquired Integrated Revenue Management, Inc.

See 6 Comparable Transactions
synopsis: Analytix On Demand, a provider of software-as-a-service business intelligence solutions for healthcare, announced that it has acquired Integrated Revenue Management, Inc., a national healthcare consulting and education company with deep roots in revenue cycle management.
buyer: Analytix On Demand, Inc.
Analytix On Demand (AOD) is a provider of software-as-a-service business intelligence solutions for healthcare. AOD connects the dots across an entire organization to give healthcare companies the central truth about business performance. "
 target: Integrated Revenue Management, Inc.
Integrated Revenue Management (IRM) is a national healthcare consulting and education company focused on improving all aspects of revenue cycle management while increasing efficiency, compliance and sustainable financial stability.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/12/2011 via BusinessWire

Intermedix Corporation, acquired Comprehensive Medical Billing Solutions, Inc.

See 94 Comparable Transactions
synopsis: Intermedix Corporation, the leading provider of technology-based business services to the emergency healthcare services industry, announced it has acquired the assets of Comprehensive Medical Billing Solutions, Inc. (“CMBS”). CMBS is a full-service medical billing, coding, and consulting firm.
buyer parent: Thomas H. Lee Partners, L.P.
buyer: Intermedix Corporation
Intermedix Corporation delivers healthcare information technology and business solutions to manage the revenue cycle, promote preparedness and interoperability, and support incident response management, documentation and reporting. "
 target: Comprehensive Medical Billing Solutions, Inc.
Comprehensive Medical Billing Solutions is a full-service medical billing, coding, and consulting firm designed to meet the business needs of Emergency Physicians. CMBS provides Practice Management, Accounts Receivables Management, and a variety of billing related services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/3/2020 via GlobeNewswire

R1 RCM, will purchase RevWorks from Cerner Corporation

See 87 Comparable Transactions
synopsis: R1 RCM, a leading provider of technology-enabled revenue cycle management services to healthcare providers, will acquire Cerner RevWorks services business and commercial, non-federal client relationships. Cerner RevWorks offers revenue cycle management outsourcing services to hospitals.
buyer: R1 RCM (RCM:$1,292.90)
R1 RCM is a leading provider of technology-enabled Revenue Cycle Management (RCM) services which transform and solve revenue cycle performance challenges across hospitals, health systems and group physician practices. "
 seller: Cerner Corporation (CERN:$5,552.99)
Cerner RevWorks offers revenue cycle management outsourcing services to hospitals. Cerner is the leading U.S. supplier of health care information technology solutions that optimize clinical and financial outcomes.
price ($mm)
$30
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/27/2018 via PE Hub

New Capital Partners, acquired Collect Rx, Inc.

See 766 Comparable Transactions
synopsis: New Capital Partners (NCP), a private equity firm, announces that is has acquired Collect Rx, a leading revenue cycle management (RCM) company. The company leverages its Business Intelligence (BI) engine to analyze claims and increase reimbursement for healthcare providers.
buyer: New Capital Partners
New Capital Partners (NCP) is a private equity firm headquartered in Birmingham, Ala. NCP makes investments in niche, tech-enabled services companies in the healthcare, financial and business services industries. "
 target: Collect Rx, Inc.
Collect Rx is a niche RCM (revenue cycle management) provider headquartered in Bethesda, Md. Founded in 2006, the company focuses on providing their services to surgery centers, hospitals, physician-owned practices, laboratory diagnostic facilities and behavioral health centers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 12/13/2017 via

IMA Consulting will be merged with Revint Solutions,

See 87 Comparable Transactions
synopsis: IMA Consulting, a full-service healthcare solutions and consulting firm, and Revint Solutions, a company that provides revenue integrity and recovery services for healthcare providers to ensure accurate and timely reimbursement for their services, announced the merger of their respective businesses.
buyer: Revint Solutions
Chicago-based Revint Solutions provides revenue integrity and recovery services for healthcare providers to ensure accurate and timely reimbursement for their services. The company provides comprehensive revenue recovery services to more than 400 healthcare clients across the United States. "
 target: IMA Consulting
IMA Consulting is a full-service healthcare solutions and consulting firm that provides outsourced solutions (revenue recovery/enhancement, underpayments, revenue cycle), consulting services, and interim management to hospitals and health systems nationwide.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/14/2014 via BusinessWire

Navigant Consulting, acquired Cymetrix Corporation

See 87 Comparable Transactions
synopsis: Navigant, a specialized, global expert services firm, has acquired Cymetrix Corporation, a privately held revenue cycle management firm that specializes in providing outsourcing services to hospital and healthcare networks. The newly acquired company will operate as Navigant Healthcare Cymetrix.
buyer: Navigant Consulting (NCI:$728.72)
Navigant Consulting is a specialized, global expert services firm dedicated to assisting clients in creating and protecting value in the face of critical business risks and opportunities. "
 target parent: Riordan, Lewis & Haden
target: Cymetrix Corporation
Cymetrix is a national leader in providing healthcare organizations and hospital-affiliated physician practices with end-to-end revenue cycle outsourcing solutions.
price ($mm)
$68
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/15/2010 via BusinessWire

Adreima, acquired Hospital Inpatient Services

See 87 Comparable Transactions
synopsis: Advanced Reimbursement Management, now known as Adreima, announced that it has acquired Hospital Inpatient Services (“HIS”), a Florida-based provider of eligibility services to hospitals on the East Coast of the US.
buyer parent: Waud Capital Partners, LLC
buyer: Adreima
Adreima advocates for hospitals nationwide, providing eligibility and revenue cycle management services supported by a deep knowledge of state-specific issues and unparalleled in-house expertise. "
 target: Hospital Inpatient Services
Hospital Inpatient Services (HIS) is a dedicated, self-pay eligibility outsourcing company. Medi-Serve, HIS' proprietary software, provides the data to streamline billing procedures, improve cash flow and delivers succinct management reports for program and revenue management.
price ($mm)
$8.15
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/23/2016 via BusinessWire

Ancor Capital Partners, acquired DuvaSawko

See 119 Comparable Transactions
synopsis: Ancor Capital Partners, an operations-oriented private equity firm, announced the acquisition of DuvaSawko, a boutique emergency-physician owned and operated revenue-cycle and practice-management company predominantly serving emergency physician groups and hospital-based emergency departments.
buyer: Ancor Capital Partners
Ancor Capital Partners is an operations-oriented private equity firm focused on lower middle-market companies with EBITDA of $5-$15 million. Extensive operational experience gives the Ancor team a unique understanding of the critical business issues faced by lower middle-market companies. "
 target: DuvaSawko
DuvaSawko is an emergency physician owned and operated Coding, Billing, Accounts Receivable and Practice Management Company. With headquarters located in Ormond Beach, Florida, DuvaSawko works with Emergency Medicine practices across the USA.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/14/2011 via BusinessWire

MedData, Inc., acquired Data Management, Inc.

See 86 Comparable Transactions
synopsis: MedData, Inc., a provider of medical billing services, announced the acquisition of Data Management, Inc. (DMI), a provider of physician billing services to pathologists and emergency departments. The acquisition adds pathology billing to MedData’s current billing specialties which include emergency medicine, hospitalists and wound care.
buyer parent: Robert W. Baird & Co. Incorporated.
buyer: MedData, Inc.
MedData is one of the nation’s leading providers of a range of medical billing services including, among others, billing, coding, collections and revenue cycle management. Annually, the company handles billing for 5.5 million patient encounters across various medical specialties. "
 target: Data Management, Inc.
Data Management, Inc. (DMI) is a leading provider of physician billing services to pathologists and emergency departments. DMI helps guide medical practices through the complexities of reimbursement and ever-changing compliance regulations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/12/2018 via PR Newswire

Fellow Health Partners, acquired Physicians Management, Inc.

See 171 Comparable Transactions
synopsis: Fellow Health Partners, Inc., a New York based medical business solutions company, announced its acquisition of Physicians Management, Inc., a long-established medical billing company based in Rochelle Park, New Jersey.
buyer: Fellow Health Partners
Fellow Health Partners Inc. is a leading-edge medical business solutions company that helps healthcare professionals and institutions to improve their bottom line by applying innovative methods of streamlining the medical billing process. "
 target: Physicians Management, Inc.
Physician Management is a leading provider of hospital and nursing home physician clinical services. They partner with hospitals throughout the Mid-Atlantic region to provide efficient, accountable and high quality physician coverage programs in multiple specialties.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/25/2018 via PR Newswire

Centauri Health Solutions, acquired NHI Billing Services

See 117 Comparable Transactions
synopsis: Centauri Health Solutions, Inc., the Scottsdale-based provider of technology-enabled revenue optimization and quality of care services, has acquired NHI Billing Services (NHI), a leading provider of Medicaid-related specialized billing services to hospitals and health systems. NHI is a full-service out-of-state Medicaid account management company.
buyer: Centauri Health Solutions
Centauri Health Solutions focuses on revealing care opportunities through its suite of products and services. Delivering services through private cloud-based software solutions, the firm provides comprehensive data management designed for risk adjustment and quality-based revenue programs. "
 target: NHI Billing Services
NHI is a full-service out-of-state Medicaid account management company providing eligibility verification, authorization notification, provider enrollment, billing, account follow-up, reporting and appeals processing for hospitals throughout the United States.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/19/2019 via PR Newswire

Health Prime International, purchased Revenue Cycle Services from Kareo, Inc.

See 107 Comparable Transactions
synopsis: Kareo, the leading provider of cloud-based clinical and business management software for independent medical practices and medical billing companies, sold its revenue cycle management (RCM) services business unit to Health Prime, a leading independent supplier of outsourced medical billing services.
buyer parent: GPB Capital Holdings, LLC
buyer: Health Prime International
Health Prime serves as a strategic partner for value-based care organizations in today’s modern consumer health care marketplace. Created by physicians for physicians, Health Prime’s transformative technology solutions and services optimize everyday practice challenges from end-to-end. "
 seller: Kareo, Inc.
Kareo is a cloud-based complete medical technology platform built to meet the needs of independent practices. Their revenue cycle management unit measures the time it takes for an average dollar to be collected from the date clients see the patient until the date they receive payment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/3/2015 via PR Newswire

Encoda, LLC., acquired Strategic Management Consultants, Inc.

See 152 Comparable Transactions
synopsis: Encoda LLC, developer of Encoda BackOffice revenue cycle management and analytics software used nationally by physician practices to improve collections, minimize denied claims and enhance medical billing software, announced it has acquired Strategic Management Consultants, provider of revenue cycle management consulting and services.
buyer: Encoda, LLC.
Encoda provides medical groups and medical billing companies with cloud-based software and technology-based transaction and business intelligence services to significantly enhance the revenue cycle management process. "
 target: Strategic Management Consultants, Inc.
Strategic Management Consultants provides revenue cycle management consulting and services throughout the central and eastern U.S. to improve financial performance in medical practices. It offers implementation, on-demand training, RCM, IT consultation, and privacy and security compliance.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/4/2012 via PR Newswire

SuccessEHS, acquired Integrated Physician Systems

See 107 Comparable Transactions
synopsis: SuccessEHS has announced the acquisition of Integrated Physician Systems (IPS), a comprehensive healthcare professional services firm. IPS offers revenue cycle management, business services and strategic advisory and consulting services to healthcare entities across the U.S.
buyer: SuccessEHS
SuccessEHS is a nationally acclaimed vendor providing Electronic Health Record and Practice Management solutions with Integrated Medical Billing Services. SuccessEHS also provides Electronic Dental Record and Dental Imaging solutions. "
 target: Integrated Physician Systems
Integrated Physician Systems provides healthcare professional services to healthcare professionals. IPS manages approximately $250 million in accounts receivable, and serves clients in the core areas of revenue cycle management, business services, and strategic advisory and consulting services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/29/2019 via Company Press Release

Netsmart Technologies, Inc., acquired McBee Associates, Inc.

See 116 Comparable Transactions
synopsis: Healthcare IT provider Netsmart announced it has acquired Pennsylvania-based healthcare consulting firm, McBee. McBee’s industry-leading healthcare professional services will provide community and acute care organizations with nearly a century of advisory and technology experience under one roof.
buyer parent: GI Partners
buyer: Netsmart Technologies, Inc. (:$59.05)
Netsmart designs, builds and delivers electronic health records (EHRs), solutions and services that are powerful, intuitive and easy-to-use.Their platform provides accurate, up-to-date information that is easily accessible to care team members in behavioral health. "
 target parent: Century Equity Partners
target: McBee Associates, Inc.
McBee is the nation’s premier health care services and consulting firm that delivers financial, operational, and clinical consulting services exclusively to healthcare providers across the continuum of care.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/19/2018 via BNC Analysis

Cognizant Technology Solutions, acquired Bolder Healthcare Solutions

See 284 Comparable Transactions
synopsis: JZ Partners has sold Bolder Healthcare Solutions (BHS) to Cognizant Technology Solutions, one of the world's leading professional services companies. BHS offers a growing suite of best of breed healthcare revenue cycle management services to the Hospital and Physician marketplace.
buyer: Cognizant Technology Solutions (CTSH:$16,752.00)
Cognizant is one of the world's leading professional services companies, transforming clients' business, operating and technology models for the digital era. Their unique industry-based, consultative approach helps clients envision, build and run more innovative and efficient businesses. "
 target parent: JZ Partners, LLC
target: Bolder Healthcare Solutions
Bolder Healthcare Solutions (BHS) offers a growing suite of best of breed healthcare revenue cycle management services to the Hospital and Physician marketplace. BHS offers unmatched expertise, processes, technology and capabilities to help healthcare providers increase cash flow.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/20/2016 via PR Web

Bolder Healthcare Solutions, acquired Prospective Payment Specialists

See 159 Comparable Transactions
synopsis: Bolder Healthcare Solutions, one of the fastest growing providers of revenue cycle management (RCM) to the healthcare market, acquired Prospective Payment Specialists, Inc, a compliance oriented hospital consulting firm with deep experience in the highly specialized medical coding and Chargemaster niche.
buyer: Bolder Healthcare Solutions
Bolder Healthcare Solutions (BHS) offers a growing suite of best of breed healthcare revenue cycle management services to the Hospital and Physician marketplace. "
 target: Prospective Payment Specialists
From HIM coding, auditing to chargemasters and RAC support, Prospective Payment Specialists (PPS), a 25-year-old hospital consulting firm, has helped more than 3,500 hospitals and health systems throughout the country achieve compliant revenue cycle management.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/4/2016 via BNC Analysis

Navigant Consulting, acquired McKinnis Consulting Services, LLC.

See 167 Comparable Transactions
synopsis: Navigant, a consultancy that serves a variety of industries, including healthcare, has acquired McKinnis Consulting Services to gain more traction in the Epic Systems business segment. McKinnis Consulting Services provides revenue cycle assessment, strategy, and optimization assistance for healthcare providers.
buyer: Navigant Consulting (NCI:$728.72)
Navigant is a consultancy that serves a variety of industries, including healthcare. Navigant’s current service lines includes revenue cycle management services that help healthcare providers assess and optimize their electronic health records and other IT systems. "
 target: McKinnis Consulting Services, LLC.
McKinnis Consulting Services provides revenue cycle assessment, strategy, and optimization assistance for healthcare providers. They focus on implementing and enhancing targeted strategies within the revenue cycle to provide maximum financial and operational benefit.
price ($mm)
$52
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
Pages:  
closed 5/14/2015 via PR Newswire

Decision Resources Group, acquired Healthcare Business Insights

See 117 Comparable Transactions
synopsis: Decision Resources Group (DRG), a subsidiary of Piramal Enterprises Ltd., announced that it has acquired Healthcare Business Insights (HBI), a trusted provider of best practice research, training and services to more than 1,400 hospitals across the U.S. HBI's member-centric Academies enable hospitals to understand how to address critical issues.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions. "
 target: Healthcare Business Insights
Healthcare Business Insights (HBI) is a leading provider of in-depth research and thoughtful insights across the core business functions found in hospitals and health systems nationwide. HBI's membership programs include Revenue Cycle, IT, Supply Chain and Cost & Quality.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/22/2020 via PR Newswire

Clarivate Analytics, will acquire Decision Resources Group

See 114 Comparable Transactions
synopsis: Clarivate Analytics plc, a global leader in providing trusted insights and analytics, will acquire Decision Resources Group ("DRG"), a premier provider of high-value data, analytics and insights products and services to the healthcare industry, from Piramal Enterprises Limited, part of global business conglomerate Piramal Group.
buyer: Clarivate Analytics (:$1,441.88)
Clarivate Analytics is a research analytics software company that provides subscription-based services in research and patent analytics. Organizations and researchers rely on the knowledge bases from Clarivate for information about pharmaceutical and biotech intelligence and IP management. "
 target parent: Piramal Group
target: Decision Resources Group
Decision Resources Group (DRG) is uniquely positioned to help healthcare businesses improve the lives of patients around the world by creating patient-centric commercial strategies that drive better outcomes and better access.
price ($mm)
$950
rev ($mm)
$207
EBITDA ($mm)
$48
EV / rev
4.6x
EV / EBITDA
20.0x
closed 8/16/2017 via PR Newswire

Decision Resources Group, acquired Context Matters

See 104 Comparable Transactions
synopsis: Decision Resources Group announced that it has completed the acquisition of Context Matters, the innovative data technology start-up that developed a first-of-its-kind global market access integrated data platform.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group (DRG), a subsidiary of Piramal Enterprises Ltd., offers best-in-class, high-value data, analytics and insights products and services to the healthcare industry, delivered by more than 900 employees across 15 offices in North America, Europe and Asia. "
 target: Context Matters
Context Matters is led by a team with extensive experience in the pharma & biotech and financial & information sectors with deep operational familiarity of the issues facing the pharmaceutical industry and those following the industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/29/2016 via PR Newswire

Decision Resources Group, acquired Adaptive Software LLC

See 607 Comparable Transactions
synopsis: Decision Resources Group (DRG) announced that it has acquired Adaptive Software. The company is a group of developers of market-leading pharmacy benefit and formulary management software platforms.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group (DRG), a subsidiary of Piramal Enterprises Ltd., offers best-in-class, high-value data, analytics and insights products and services to the healthcare industry, delivered by more than 900 employees across 15 offices in North America, Europe and Asia. "
 target: Adaptive Software LLC
Adaptive Software, located in Kansas City, currently offers to health plans and Pharmacy Benefit Managers (PBMs) a suite of software solutions that streamlines formulary management, pharmacy networking, pricing, and pharmacy benefit design.
price ($mm)
$7.40
rev ($mm)
$3
EBITDA ($mm)
EV / rev
7.7x
EV / EBITDA
closed 5/14/2015 via PR Newswire

Decision Resources Group, acquired Healthcare Business Insights

See 117 Comparable Transactions
synopsis: Decision Resources Group (DRG), a subsidiary of Piramal Enterprises Ltd., announced that it has acquired Healthcare Business Insights (HBI), a trusted provider of best practice research, training and services to more than 1,400 hospitals across the U.S. HBI's member-centric Academies enable hospitals to understand how to address critical issues.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions. "
 target: Healthcare Business Insights
Healthcare Business Insights (HBI) is a leading provider of in-depth research and thoughtful insights across the core business functions found in hospitals and health systems nationwide. HBI's membership programs include Revenue Cycle, IT, Supply Chain and Cost & Quality.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/2/2015 via PR Newswire

Decision Resources Group, acquired Activate Networks

See 164 Comparable Transactions
synopsis: Decision Resources Group, a leading research and advisory company focused on high-value healthcare data, insights and analytics, announced that it acquired Activate Networks. Their analytics platform and suite of SaaS software applications enable healthcare/life sciences companies to unlock the commercial value of their customer networks.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions. "
 target: Activate Networks
Activate Networks, Inc. is the leading provider of network analytics for healthcare/life sciences companies. Their analytics platform and suite of SaaS software applications enable healthcare/life sciences companies to unlock the commercial value of their customer networks.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/7/2014 via PR Newswire

Decision Resources Group, acquired Relay Technology Management

See 200 Comparable Transactions
synopsis: Piramal Enterprises' Information Management Subsidiary, Decision Resources Group, one of the world's leading research and advisory firms focusing on high-value healthcare insights and analytics, announced that it acquired Relay Technology Management, a data analytics company focused on the life-sciences industry.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions. "
 target: Relay Technology Management
Relay Technology Management is a life sciences business intelligence software provider founded in 2008 with one core belief: that enabling data-driven decision-making via objective, standard asset valuation and trend analytics will lead to increased efficiency in drug development.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/4/2012 via BusinessWire

Decision Resources Group, acquired Abacus International

See 55 Comparable Transactions
synopsis: Decision Resources Group, one of the world’s leading research and advisory firms focusing on healthcare insights and analysis, announced that it has acquired Abacus International, a pioneer in evidence-based global market access solutions for many of the world’s leading healthcare companies.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions. "
 target: Abacus International
Abacus International is unique in its provision of services throughout the lifecycle of a pharmaceutical or medical device. They can provide tailored solutions to overcome each hurdle of the product development process, from pre-launch though to market access.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/11/2012 via BNC Analysis

Piramal Healthcare Limited, acquired Decision Resources Group

See 90 Comparable Transactions
synopsis: Piramal Healthcare Limited has completed its previously announced acquisition of Decision Resources Group, a US based company in the healthcare information segment. Decision Resources Group is a cohesive portfolio of companies that offers best in class, high-value information and insights on important sectors of the healthcare industry.
buyer parent: Piramal Group
buyer: Piramal Healthcare Limited
With assets across North America, Europe and Asia, Piramal Healthcare is one of the largest pharmaceutical custom manufacturing companies across the world. It has significant presence in the global critical care space with sales of anesthesia products to over 100 countries. "
 target parent: Providence Equity Partners Inc.
target: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions.
price ($mm)
$635
rev ($mm)
$160
EBITDA ($mm)
EV / rev
4.0x
EV / EBITDA
closed 4/17/2012 via BusinessWire

Decision Resources Group, acquired Pinsonault Associates, LLC.

See 42 Comparable Transactions
synopsis: Decision Resources Group, one of the world’s leading research and advisory firms focusing on healthcare insights and analysis, announced that it acquired Pinsonault, a leading provider in offering managed markets-specific business and training solutions to the pharmaceutical and biotech industries.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions. "
 target: Pinsonault Associates, LLC.
Pinsonault is dedicated to and focused on delivering high quality, Managed Markets specific, business and training solutions within the pharmaceutical and biotech industries.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/25/2011 via BusinessWire

Decision Resources Group, acquired PharmaStrat, Inc.

See 9 Comparable Transactions
synopsis: Decision Resources Group, one of the world’s leading research and advisory firms focusing on healthcare insights and analysis, has acquired PharmaStrat, the leading consulting and market research services firm focused on issues related to reimbursement and organized customer segments for biopharmaceutical manufacturers.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information, insights, advisory services and consulting on important sectors of the healthcare industry. "
 target: PharmaStrat, Inc.
PharmaStrat is the leading consulting and market research services firm focused on issues related to reimbursement and organized customer segments for biopharmaceutical manufacturers. It delivers strategic perspectives and market insight solutions that proactively address challenges and opportunity.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/19/2010 via PR Newswire

Decision Resources, Inc., acquired BioTrends Research Group, Inc.

See 59 Comparable Transactions
synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on healthcare insights and analysis, announced that it acquired BioTrends Research Group, the leader in providing specialized, syndicated market research in clinically complex, small to mid-size pharmaceutical markets.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit. "
 target: BioTrends Research Group, Inc.
BioTrends Research Group, Inc. provides syndicated and custom market research to pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/17/2008 via PR Newswire

Decision Resources, Inc., acquired Manhattan Research, Inc.

See 4 Comparable Transactions
synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on healthcare insights and analysis, announced that it acquired Manhattan Research, a leading provider of access to physician and consumer opinions on the global healthcare market.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit. "
 target: Manhattan Research, Inc.
Manhattan Research is a healthcare market research and advisory services firm, bringing clarity to the market forces, trends, and impacts of physician and consumer use of information technology, including next generation digital media such as social networking, blogs, podcasts, and Web 2.0.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/17/2008 via Company Press Release

Decision Resources, Inc., acquired Fingertip Formulary

See 36 Comparable Transactions
synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare industry insight and analysis, announced that it acquired Fingertip Formulary, the leading provider of access to and insight into formulary data in the United States.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit. "
 target: Fingertip Formulary
Fingertip Formulary offers comprehensive formulary data covering commercial, Medicaid, Medicare, and PBM plans, among others, in the United States. Fingertip Formulary offers a variety of unique data and marketing solutions that provide access to and insight into formulary data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/19/2007 via PR Newswire

Decision Resources, Inc., acquired Arlington Medical Resources Inc.

See 59 Comparable Transactions
synopsis: Berkery Noyes, the leading independent investment bank serving the media, information and technology markets, announces that it represented Arlington Medical Resources, Inc. in its sale to Decision Resources, Inc., a portfolio company of Providence Equity Partners, Inc. Terms of the transaction were not disclosed.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit. "
 target: Arlington Medical Resources Inc.
AMR is a privately held pharmaceutical market research firm headquartered in suburban Philadelphia. We have been serving the market research needs of the pharmaceutical & diagnostic imaging industries since 1988.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/20/2007 via

Decision Resources, Inc., purchased Life Sciences business from Wood Mackenzie

See 65 Comparable Transactions
synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, announced that it plans to acquire Wood Mackenzie's Life Sciences business.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit. "
 seller: Wood Mackenzie
Wood Mackenzie has been providing its unique range of consulting services and research products to the Energy and Life Sciences industries for over 30 years. Our market proposition is based on our ability to provide forward- looking insight that enables our clients to make better business decisions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/10/2007 via

Providence Equity Partners Inc., acquired Decision Resources, Inc.

See 48 Comparable Transactions
synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, announced today that Providence Equity Partners, a leading private equity firm with more than $21 billion under management, will acquire majority control of the Company.
buyer: Providence Equity Partners Inc.
Providence Equity Partners Inc. is a private investment firm specializing in equity investments in communications and media companies around the world. The principals of Providence Equity manage funds with approximately $21 billion in equity commitments. "
 target parent: Boston Ventures Management, Inc.
target: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/2/2006 via PR Newswire

Decision Resources, Inc., acquired Millennium Research Group

See 4 Comparable Transactions
synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare industry insight and analysis, announced today that it acquired Millennium Research Group, the global authority on medical technology market intelligence.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit. "
 target: Millennium Research Group
Millennium Research Group is a leading provider of strategic information to the healthcare sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the Company provides its clients with the benefits of its specialized industry expertise through published reports.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/22/2005 via BusinessWire

HCPro, acquired HealthLeaders, Inc.

See 329 Comparable Transactions
synopsis: HCPro, Inc. today announced it has significantly broadened its healthcare publishing lines by acquiring HealthLeaders Media from Decision Resources, Inc. The acquisition includes the monthly HealthLeaders magazine, several general healthcare business email publications, live events and a state-specific healthcare business news service.
buyer parent: The Riverside Company
buyer: HCPro
HCPro is a leading provider of integrated information, education, training, and consulting products and services in the vital areas of healthcare regulation and compliance. The company's mission is to meet the specialized informational, advisory, and educational needs of the healthcare industry. "
 target parent: Boston Ventures Management, Inc.
target: HealthLeaders, Inc.
HealthLeaders is a leading multi-platform media company dedicated to meeting the business information needs of healthcare executives and professionals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/6/2004 via PR Newswire

Boston Ventures Management, Inc., Castanea Partners, acquired Decision Resources, Inc.

See 48 Comparable Transactions
synopsis: Castanea Partners and Boston Ventures Limited Partnership VI today announced the recapitalization of Decision Resources, Inc., with a total transaction value of $58 million. The Waltham, Massachusetts-based company is best known for its therapeutically-focused analyses of global pharmaceutical and biotechnology markets.
buyer: Boston Ventures Management, Inc.
buyer: Castanea Partners
Boston Ventures Management, LLC is a private equity firm that has been an active investor and financial partner to management teams in the media, entertainment, publishing and information and communications sectors since 1983, earning the firm a franchise position in the private equity community. "
 target: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit.
price ($mm)
$58
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/22/2020 via PR Newswire

Clarivate Analytics, will acquire Decision Resources Group

See 114 Comparable Transactions
synopsis: Clarivate Analytics plc, a global leader in providing trusted insights and analytics, will acquire Decision Resources Group ("DRG"), a premier provider of high-value data, analytics and insights products and services to the healthcare industry, from Piramal Enterprises Limited, part of global business conglomerate Piramal Group.
buyer: Clarivate Analytics (:$1,441.88)
Clarivate Analytics is a research analytics software company that provides subscription-based services in research and patent analytics. Organizations and researchers rely on the knowledge bases from Clarivate for information about pharmaceutical and biotech intelligence and IP management. "
 target parent: Piramal Group
target: Decision Resources Group
Decision Resources Group (DRG) is uniquely positioned to help healthcare businesses improve the lives of patients around the world by creating patient-centric commercial strategies that drive better outcomes and better access.
price ($mm)
$950
rev ($mm)
$207
EBITDA ($mm)
$48
EV / rev
4.6x
EV / EBITDA
20.0x
closed 5/21/2019 via BusinessWire

Xcenda, acquired Dymaxium, Inc.

See 95 Comparable Transactions
synopsis: Xcenda, a part of AmerisourceBergen, announced the acquisition of Dymaxium, a trusted market access partner specializing in the exchange of evidence and information between payers and life science companies through its FormularyDecisions.com® platform.
buyer parent: AmerisourceBergen Corporation
buyer: Xcenda
Xcenda, part of AmerisourceBergen, is a strategic consultancy with 20+ years of experience applying real-world expertise in health economics and outcomes research, reimbursement, stakeholder insights, and market access consulting and communications. "
 target: Dymaxium, Inc.
Dymaxium is a trusted market access partner specializing in the exchange of evidence and information between payers and life science companies through its FormularyDecisions.com® platform.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/7/2016 via BNC Analysis

M3, Inc., will acquire Vidal Group

See 51 Comparable Transactions
synopsis: Electra Partners’ portfolio company AXIO Group has received a binding offer from M3 Inc. to purchase Vidal Group, a European provider of reference drug information. Vidal Group provides hospitals, primary care physicians, pharmacists, and patients with on-line access to up-to-date drug databases and related treatment-based information.
buyer: M3, Inc. (TSE:2413:$1,127.03)
M3 Inc. represents the three Ms of Medicine, Media, and Metamorphosis. Their company was founded with the goal of changing the world of medicine through making full use of the power of the Internet. "
 target parent: Electra Partners LLP
target: Vidal Group
Vidal Group is a leading European healthcare informatics and information systems company. Vidal Group provides hospitals, primary care physicians, pharmacists, and patients across Europe with on-line access to up-to-date drug databases and related treatment-based information.
price ($mm)
$133
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/30/2016 via BNC Analysis

Affinity Equity Partners, will acquire MedicalDirector

See 941 Comparable Transactions
synopsis: Leading Asian private equity firm Affinity Equity Partners agreed to acquire Sydney-based MedicalDirector (formerly Health Communication Network) from Australia’s Primary Health Care Ltd. MedicalDirector is a leading provider of clinical and enterprise software solutions to general practitioners, medical specialists and allied health professionals.
buyer: Affinity Equity Partners
Affinity Equity Partners is an independently-owned buyout fund manager comprising primarily the former investment professionals of UBS Capital Asia Pacific. They are pioneers in buyout investments in the Asia-Pacific region, with an established and widely recognised franchise. "
 target parent: Primary Health Care Limited
target: MedicalDirector
MedicalDirector has been supporting healthcare professionals and improving health outcomes for more than 20 years. They provide software for practice management, optimizing patient outcomes, and access to Australia's most comprehensive and up-to-date pharmaceutical database.
price ($mm)
$119
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/26/2015 via Company Press Release

Inovalon, Inc., will acquire Avalere Health LLC

See 85 Comparable Transactions
synopsis: Inovalon, a leading technology company providing cloud-based analytics and data-driven intervention platforms to the healthcare industry, has entered into a definitive agreement to acquire Avalere Health, Inc., a leading provider of data-driven advisory services and business intelligence solutions to the pharmaceutical and life sciences industry.
buyer: Inovalon, Inc. (INOV:$449.36)
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape. "
 target: Avalere Health LLC
Avalere Health, Inc. is a leading provider of data-driven advisory services and business intelligence solutions to the pharmaceutical and life sciences industry.
price ($mm)
$140
rev ($mm)
$47
EBITDA ($mm)
EV / rev
3.0x
EV / EBITDA
closed 12/4/2012 via BusinessWire

Decision Resources Group, acquired Abacus International

See 55 Comparable Transactions
synopsis: Decision Resources Group, one of the world’s leading research and advisory firms focusing on healthcare insights and analysis, announced that it has acquired Abacus International, a pioneer in evidence-based global market access solutions for many of the world’s leading healthcare companies.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions. "
 target: Abacus International
Abacus International is unique in its provision of services throughout the lifecycle of a pharmaceutical or medical device. They can provide tailored solutions to overcome each hurdle of the product development process, from pre-launch though to market access.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/11/2012 via BNC Analysis

Piramal Healthcare Limited, acquired Decision Resources Group

See 90 Comparable Transactions
synopsis: Piramal Healthcare Limited has completed its previously announced acquisition of Decision Resources Group, a US based company in the healthcare information segment. Decision Resources Group is a cohesive portfolio of companies that offers best in class, high-value information and insights on important sectors of the healthcare industry.
buyer parent: Piramal Group
buyer: Piramal Healthcare Limited
With assets across North America, Europe and Asia, Piramal Healthcare is one of the largest pharmaceutical custom manufacturing companies across the world. It has significant presence in the global critical care space with sales of anesthesia products to over 100 countries. "
 target parent: Providence Equity Partners Inc.
target: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions.
price ($mm)
$635
rev ($mm)
$160
EBITDA ($mm)
EV / rev
4.0x
EV / EBITDA
closed 7/22/2010 via Company Press Release

CT Corsearch, acquired Edital

See 24 Comparable Transactions
synopsis: CT Corsearch, the premier provider of clearance and protection solutions for trademark and brand professionals, announced it’s acquired Edital, the Questel trademark branch. This acquisition will create best-in-class solutions for managing a brand lifecycle globally—from creation to watching to protecting, maintaining and renewing a brand.
buyer parent: Wolters Kluwer NV
buyer: CT Corsearch
CT Corsearch provides high-quality, intuitive tools and expertise that trademark professionals need to effectively manage the trademark screening, search review and watching processes. "
 target parent: Questel
target: Edital
Edital was established in Brussels in 1982 and acquired by Questel, a world leader in Intellectual Property in 2005. Its sole purpose has been to create global solutions for the Intellectual Property professional.
price ($mm)
rev ($mm)
$8
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 9/27/2007 via PR Newswire

Thomson Pharma, acquired Prous Science

See 63 Comparable Transactions
synopsis: The Thomson Corporation, a leading provider of information solutions to business and professional customers worldwide, today announced that it has acquired Prous Science, a global leader in the provision of life sciences information solutions. Prous Science will become part of Thomson Scientific.
buyer parent: The Thomson Corporation
buyer: Thomson Pharma (:$1,441.88)
Thomson Scientific & Healthcare provides integrated information solutions to researchers and librarians, physicians and pharmacists, and other professionals worldwide. "
 target: Prous Science
Prous Science is a trusted source of information on which science depends to discover safer and more effective medicines. The company's products have evolved through the years from print journals to sophisticated electronic products incorporating the latest advances in IT.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/15/2007 via Company Description

MergerMarket, acquired Infinata, Inc.

See 166 Comparable Transactions
synopsis: In September 2007, Mergermarket acquired Infinata, an information solutions and marketing analytics provider to the global financial service, life science, and high technology industries.
buyer parent: Pearson plc
buyer: MergerMarket
MergerMarket, part of Pearson's Financial Times Group, is an unparalleled, independent M&A intelligence tool used by the world's foremost financial institutions to originate deals. It provides proprietary intelligence on potential deal flow, potential mandates and valuations. "
 target: Infinata, Inc.
Infinata is an innovative provider of information solutions and marketing analytics to the global financial service, life science, and high-tech industries. Our information suites include: BioPharm Insight, High Net Worth Insight, and Corporate Tracker.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/7/2019 via BNC Analysis

Inflexion Private Equity Partners LLP, will acquire Pharmaspectra

See 52 Comparable Transactions
synopsis: Inflexion Private Equity, a UK mid-market private equity firm, will acquire Pharmaspectra, a global provider of medical affairs data to the pharmaceutical and biotech industry. Pharmaspectra offers the world's largest database for medical scientific literature and biomedical literature.
buyer: Inflexion Private Equity Partners LLP
Inflexion is a UK mid-market private equity firm. They invest in high growth, entrepreneurial businesses and work with them to accelerate growth. Inflexion’s flexible approach allows it to back both majority and minority investments, typically investing £10m to £150m of equity in each deal. "
 target: Pharmaspectra
Pharmaspectra is a global provider of medical affairs data to the pharmaceutical and biotech industry. Pharmaspectra offers the world's largest database for medical scientific literature and biomedical literature. Their web-based solutions analyze data across the entire medical continuum.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/3/2013 via Company Press Release

JISC Collections, acquired SpringerProtocols

See 85 Comparable Transactions
synopsis: Springer announced that JISC Collections has purchased the archive content of SpringerProtocols; the world’s largest database of life sciences protocols. SpringerProtocols contains more than 31,000 protocols, most of which come from the classic book series “Methods in Molecular Biology”.
buyer: JISC Collections
JISC Collections supports the procurement of digital content for education and research in the UK. They are uniquely placed to provide members with: expertise in negotiating and procurement, within the scholarly communications sector. "
 target parent: EQT
target: SpringerProtocols
SpringerProtocols combines the world’s largest collection of life sciences and bio-medicine protocols with advanced search functionality. Used primarily in the life sciences, the protocols provide sets of instructions that allow scientists to recreate experiments in their own laboratories.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/8/2016 via PR Newswire

Nordic Capital, will acquire ERT

See 58 Comparable Transactions
synopsis: Genstar Capital, a leading private equity firm focused on the healthcare, software, financial services, and industrial technology industries, announced the sale of ERT, a leading provider of high-quality patient data collection solutions for use in clinical drug development, to Nordic Capital Fund VIII.
buyer: Nordic Capital
Nordic Capital is a leader in Nordic private equity investments, and now has an enviable reputation in investment and portfolio management. Since launching in 1989, Nordic Capital funds have delivered outstanding returns for our investors. "
 target parent: Genstar Capital LLC
target: ERT
ERT is a leading provider of high-quality patient data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the widely deployed solutions.
price ($mm)
rev ($mm)
$300
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 2/7/2013 via Wall Street Journal

Wilmington Group plc, acquired NHiS Ltd

See 109 Comparable Transactions
synopsis: Wilmington Group plc, the provider of Information, Compliance, and Education to professional markets announced the acquisition of the entire issued and to be issued share capital of NHiS Limited. NHiS is a leading provider of business intelligence, data analysis, workflow tools and other services to pharmaceutical companies in the UK.
buyer: Wilmington Group plc (LSE:WIL:$162.62)
Wilmington Group plc is a dynamic and expanding company providing information and training to professional business markets. Their businesses enable professionals and their organizations to perform better by providing quality, relevant and reliable information, education and knowledge. "
 target: NHiS Ltd
NHiS is the leading provider of market intelligence and insight to the pharmaceutical sector. NHiS’s products assist organizations in their understanding, engagement and optimization of their markets.
price ($mm)
$8.82
rev ($mm)
$3
EBITDA ($mm)
EV / rev
5.2x
EV / EBITDA
closed 7/3/2012 via PR Newswire

Genstar Capital LLC, acquired ERT

See 58 Comparable Transactions
synopsis: ERT, a global technology-driven provider of health outcomes services to biopharmaceutical sponsors and contract research organizations, announced that Genstar Capital, LLC, has completed its acquisition of the company in a take-private transaction.
buyer: Genstar Capital LLC
Genstar Capital LLC has more than $3 billion of committed capital under management and targets investments focused on selected sectors within the life science, healthcare services, software and software services, insurance and financial services, and industrial technology industries. "
 target: ERT
ERT is a global technology-driven provider of health outcomes research services and customizable medical devices supporting biopharmaceutical sponsors and contract research organizations to achieve their drug development and healthcare objectives.
price ($mm)[EV]
$395 [$370]
rev ($mm)
$194
EBITDA ($mm)
$42
EV / rev
1.9x
EV / EBITDA
9.0x
closed 9/13/2011 via PR Newswire

ImpactRx, Inc., acquired TargetRx, Inc.

See 4 Comparable Transactions
synopsis: ImpactRx, a Symphony Technology Group company and the pioneer in measuring the impact of promotion on physician prescribing behavior, announced that it has acquired 100% of TargetRx, Inc., a leading provider of insight into the drivers of physician behavior for pharmaceutical companies.
buyer parent: Symphony Technology Group
buyer: ImpactRx, Inc.
ImpactRx is the leading provider of consultative and analytically-based promotional effectiveness solutions to the healthcare industry. ImpactRx's ImpactData™ is the industry’s sole source of continuous-capture market promotion and physician treatment data. "
 target: TargetRx, Inc.
TargetRx, Inc. is a leading provider of insight into the drivers of physician behavior for pharmaceutical companies. The company offers a suite of solutions from pipeline to patent expiry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/3/2016 via PR Newswire

IMS Health Incorporated, acquired AlphaImpactRx, Inc

See 75 Comparable Transactions
synopsis: Symphony Technology Group announced the closing of the sale of AlphaImpactRx, a leading provider of primary research and analytics-based insight for biopharmaceutical and consumer health companies to IMS Health, a global information and technology services company serving the healthcare industry.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. They connect configurable SaaS applications to complex healthcare data in the IMS One™ cloud platform. "
 target parent: Symphony Technology Group
target: AlphaImpactRx, Inc
AlphaImpactRx is the leading provider of primary research-based insights, analytics and solutions to pharmaceutical, consumer health and medical device companies. They provide market research to help its global healthcare clients make informed and business decisions to market their products.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/18/2011 via PR Newswire

Symphony Technology Group, acquired ImpactRx, Inc.

See 4 Comparable Transactions
synopsis: ImpactRx, the pioneer in measuring the impact of promotion on physician prescribing behavior, announced that Symphony Technology Group (STG), has acquired a majority ownership interest in the Company. STG is a leading private equity firm with a strategic focus on data, analytics and technology-enabled services companies.
buyer: Symphony Technology Group
Symphony Technology Group (STG) is a strategic private equity firm with the mission of investing in and building great software and services companies. STG also provides transformation expertise to enable its companies to deliver maximum value to its clients. "
 target: ImpactRx, Inc.
ImpactRX annually captures three-million treatment decisions, fueling its unique ImpactData™ industry database. ImpactRx leverages this unprecedented intelligence with custom research and analytics to provide insightful solutions to pharmaceutical marketing and sales decision makers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/16/2017 via PR Newswire

Decision Resources Group, acquired Context Matters

See 104 Comparable Transactions
synopsis: Decision Resources Group announced that it has completed the acquisition of Context Matters, the innovative data technology start-up that developed a first-of-its-kind global market access integrated data platform.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group (DRG), a subsidiary of Piramal Enterprises Ltd., offers best-in-class, high-value data, analytics and insights products and services to the healthcare industry, delivered by more than 900 employees across 15 offices in North America, Europe and Asia. "
 target: Context Matters
Context Matters is led by a team with extensive experience in the pharma & biotech and financial & information sectors with deep operational familiarity of the issues facing the pharmaceutical industry and those following the industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/26/2020 via PR Newswire

Arsenal Capital Partners, acquired BresMed Health Solutions Ltd

See 209 Comparable Transactions
synopsis: Arsenal Capital Partners, a leading private equity firm investing in healthcare and specialty industrials companies, announced the acquisition of BresMed Health Solutions, a pioneer in providing health economic research, communications, and consulting services to the global pharmaceutical industry.
buyer: Arsenal Capital Partners
Arsenal is a leading private equity firm that specializes in investments in middle‐market specialty industrials and healthcare companies. Since its inception in 2000, Arsenal has raised institutional equity investment funds of $5.3 billion, and completed more than 45 platform investments. "
 target: BresMed Health Solutions Ltd
BresMed is a health economic and outcomes research consultancy that provides health economic solutions to the global pharmaceutical industry. Established in 2006, BresMed has more than 150 staff across offices in the U.K., Ireland, the Netherlands, the U.S., and India.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
Pages:  

Like Healthcare Business Insights


read more

Healthcare Business Insights

Workforce Prescriptions (WRx)

Integrated Revenue Management, Inc.

Comprehensive Medical Billing Solutions, Inc.

Cerner Corporation

Collect Rx, Inc.

IMA Consulting

Cymetrix Corporation

Hospital Inpatient Services

DuvaSawko

Data Management, Inc.

Physicians Management, Inc.

NHI Billing Services

Kareo, Inc.

Strategic Management Consultants, Inc.

Integrated Physician Systems

McBee Associates, Inc.

Bolder Healthcare Solutions

Prospective Payment Specialists

McKinnis Consulting Services, LLC.

Pages:  
read more

Healthcare Business Insights

read more

Decision Resources Group

Context Matters

Adaptive Software LLC

Healthcare Business Insights

Activate Networks

Relay Technology Management

Abacus International

Decision Resources Group

Pinsonault Associates, LLC.

PharmaStrat, Inc.

BioTrends Research Group, Inc.

Manhattan Research, Inc.

Fingertip Formulary

Arlington Medical Resources Inc.

Wood Mackenzie

Decision Resources, Inc.

Millennium Research Group

HealthLeaders, Inc.

Decision Resources, Inc.

read more

Decision Resources Group

Dymaxium, Inc.

Vidal Group

MedicalDirector

Avalere Health LLC

Abacus International

Decision Resources Group

Edital

Prous Science

Infinata, Inc.

Pharmaspectra

SpringerProtocols

ERT

NHiS Ltd

ERT

TargetRx, Inc.

AlphaImpactRx, Inc

ImpactRx, Inc.

Context Matters

BresMed Health Solutions Ltd

Pages:  
Geography
Matching Companies
Ticker: NRCI.B
 
 
 
 
 
 
 
 
NRC Health
NRC Health
NRC Health has helped healthcare organizations illuminate and improve the moments that matter to patients, residents, physicians, nurses, and staff for 35 years.
year
2015
rev ($mm)
$101.10
EBITDA ($mm)
$29.31
EBIT ($mm)
$25.21
Net Income ($mm)
$15.78
Employees
380
  • drill down
  • watch
Ticker: PGND
 
 
 
 
 
 
 
 
Press Ganey Associates, Inc.
Press Ganey Associates, Inc.
Press Ganey offers an integrated suite of solutions that enables enterprise transformation across the patient journey. Delivered through a cutting-edge digital platform, Press Ganey solutions address safety, clinical excellence, patient experience, and workforce engagement.
year
2016
rev ($mm)
$344.32
EBITDA ($mm)
$104.94
EBIT ($mm)
$60.70
Net Income ($mm)
$27.26
Employees
1058
  • drill down
  • watch
Ticker: TSE:2413
 
 
 
 
 
 
 
 
M3.com
M3.com
M3.com is Japan's largest portal site dedicated to healthcare professionals. M3.com provides the latest medical news, overseas journal article summaries, and medical resources. The portal offers information on clinical trials and other services in the healthcare and pharmaceutical industries.
year
2019
rev ($mm)
$1,015.17
EBITDA ($mm)
$288.13
EBIT ($mm)
$275.64
Net Income ($mm)
$175.78
Employees
5165
  • drill down
  • watch
Ticker: TSE:2413
 
 
 
 
 
 
 
 
M3, Inc.
M3 Inc. represents the three Ms of Medicine, Media, and Metamorphosis. Their company was founded with the goal of changing the world of medicine through making full use of the power of the Internet.
year
2019
rev ($mm)
$1,127.03
EBITDA ($mm)
$319.84
EBIT ($mm)
$286.78
Net Income ($mm)
$193.56
Employees
6024
  • drill down
  • watch
Ticker: TSE:6095
 
 
 
 
 
 
 
 
MedPeer,Inc.
MedPeer,Inc.
MedPeer provides appropriate services at every stage of the clinical process physicians are involved in day-to-day clinical operation. Drug Evaluation provides detailed peer reviews of prescription drugs, and Meet the Experts allows members to consult expert physicians in specific therapeutic areas.
year
2016
rev ($mm)
$9.13
EBITDA ($mm)
$0.94
EBIT ($mm)
$0.39
Net Income ($mm)
$0.20
Employees
44
  • drill down
  • watch